Literature DB >> 14694153

Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.

Antonella Liantonio1, Michael Pusch, Alessandra Picollo, Patrizia Guida, Annamaria De Luca, Sabata Pierno, Giuseppe Fracchiolla, Fulvio Loiodice, Paolo Tortorella, Diana Conte Camerino.   

Abstract

CLC-K chloride channels are expressed in the kidney, where they play a pivotal role in the mechanisms of urine concentration and Na(+) reabsorption. The identification of barttin as an essential beta-subunit of CLC-K channels allowed performance of a pharmacologic characterization of wild-type CLC-K1 expressed in Xenopus oocytes. To this end, a series of 2-(p-chlorophenoxy)propionic acid (CPP) derivatives were screened using the two-microelectrode voltage-clamp technique. Several chemical modifications regarding the phenoxy group of the side chain (elimination of the oxygen atom or of methylenic groups, substitutions of the chlorine atom) did not alter the drug blocking activity, with five different derivatives showing a similar potency. Among these, a derivative of CPP carrying a benzyl group on the chiral center in the place of the methyl group represented the minimal structure for blocking CLC-K1. It inhibited the channel from the extracellular side with an affinity in the 150 micro M range. The blocking potency of this compound is fourfold increased by lowering the extracellular chloride concentration, suggesting that the drug interacts with the channel pore. Concomitantly, the effect of some "classical" Cl(-) channel blockers (9-anthracenecarboxylic acid, 2-(phenylamino)benzoic acid, iminodibenzoic acid, niflumic acid, 5-nitro-2-(3-phenylpropylamino)benzoic acid, 4,4'-diisothiocyanato-2,2'-stilbenedisulfonic acid disodium salt, and 4-acetamido-4'-isothiocyanato-2,2'-stilbenedisulfonic acid disodium salt) was screened. 4,4'-Diisothiocyanato-2,2'-stilbenedisulfonic acid disodium salt was the only one capable of blocking CLC-K1 with a potency similar to the CPP derivative, although in an irreversible manner. The newly identified substances provide a useful tool to investigate the biophysical and physiologic role of these renal channels and a starting point for the development of therapeutic drugs with diuretic action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694153     DOI: 10.1097/01.asn.0000103226.28798.ea

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

Review 1.  CLC-K channels: if the drug fits, use it.

Authors:  Peying Fong
Journal:  EMBO Rep       Date:  2004-06       Impact factor: 8.807

2.  Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.

Authors:  G Zifarelli; A Liantonio; A Gradogna; A Picollo; G Gramegna; M De Bellis; A R Murgia; E Babini; D Conte Camerino; M Pusch
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Role of kidney chloride channels in health and disease.

Authors:  I Elias Veizis; Calvin U Cotton
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

4.  Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study.

Authors:  S Pierno; M P Didonna; V Cippone; A De Luca; M Pisoni; A Frigeri; G P Nicchia; M Svelto; G Chiesa; C Sirtori; E Scanziani; C Rizzo; D De Vito; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

5.  Inhibition of transmembrane member 16A calcium-activated chloride channels by natural flavonoids contributes to flavonoid anticancer effects.

Authors:  Xuan Zhang; Honglin Li; Huiran Zhang; Yani Liu; Lifang Huo; Zhanfeng Jia; Yucong Xue; Xiaorun Sun; Wei Zhang
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

Review 6.  Novel diuretic targets.

Authors:  Jerod S Denton; Alan C Pao; Merritt Maduke
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

7.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.

Authors:  Antonella Liantonio; Alessandra Picollo; Giuseppe Carbonara; Giuseppe Fracchiolla; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza; Elena Babini; Giovanni Zifarelli; Michael Pusch; Diana Conte Camerino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

8.  Characteristics of Cl- uptake in rat alveolar type I cells.

Authors:  Meshell Johnson; Lennell Allen; Leland Dobbs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

9.  Natural and synthetic flavonoids, novel blockers of the volume-regulated anion channels, inhibit endothelial cell proliferation.

Authors:  Yucong Xue; Honglin Li; Yuanyuan Zhang; Xue Han; Gaohua Zhang; Wenya Li; Huiran Zhang; Yue Lin; Pingping Chen; Xiaorun Sun; Yalei Liu; Li Chu; Jianping Zhang; Mingyun Zhang; Xuan Zhang
Journal:  Pflugers Arch       Date:  2018-06-30       Impact factor: 3.657

10.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.

Authors:  Alessandra Picollo; Antonella Liantonio; Maria Paola Didonna; Laura Elia; Diana Conte Camerino; Michael Pusch
Journal:  EMBO Rep       Date:  2004-05-28       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.